25(OH)D3 Affects the Maturation and Function of Mouse Bone Marrow-Derived Dendritic Cells Stimulated by Mycobacterium Bovis BCG

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Yang, Hui feng ^a   Zhang, Ze hua ^a   Xiang, Liang bi ^b   Tang, Kang lai ^a   Luo, Fei ^a   Liu, Chun yu ^a   Zhou, Jian bo ^a   Li, Jin qing ^a   Xu, Jian zhong ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b GENERAL HOSPITAL OF NORTHERN THEATER COMMAND   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; CALCIFEDIOL; CD86 ANTIGEN; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; BONE MARROW DERIVED DENDRITIC CELL; CELL CULTURE; CELL FUNCTION; CELL MATURATION; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; IMMUNE RESPONSE; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; MYCOBACTERIUM BOVIS; NONHUMAN;

25-HYDROXYVITAMIN D3 1-ALPHA-HYDROXYLASE; ANIMALS; ANTIGENS, CD; BONE MARROW CELLS; CALCIFEDIOL; CELL PROLIFERATION; CELL SHAPE; CELLS, CULTURED; COCULTURE TECHNIQUES; CYTOKINES; DENDRITIC CELLS; GENE EXPRESSION; HISTOCOMPATIBILITY ANTIGENS CLASS II; HOST-PATHOGEN INTERACTIONS; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED C57BL; MYCOBACTERIUM BOVIS; RECEPTORS, CALCITRIOL; T-LYMPHOCYTES;

MUS; MYCOBACTERIUM BOVIS BCG; MYCOBACTERIUM TUBERCULOSIS;

EID: 84868347406     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0048062     Document Type: Article

References (41)

1. World Health Organization (2011) Global tuberculosis control 2011. IOP Publishing PhysicsWeb. Available: http://www.who.int/tb/publications/global_report/en/. Accessed 2010 Jul.
2. Goswami R, Mishra SK, Kochupillai N, (2008) Prevalence & potential significance of vitamin D deficiency in Asian Indians. Indian J Med Res 127: 229-38.
3. Aziz MA, Wright A, Laszlo A, De Muynck A, Portaels F, et al. (2006) Epidemiology of antituberculosis drug resistance.The Lancet. 368: 2142-2154.
4. Pillay M, Sturm AW, (2007) Evolution of the extensively drug-resistant F15/LAM4/KZN strain of Mycobacterium tuberculosis in KwaZulu-Natal, South Africa. Clinical infectious diseases 45: 1409-14.
5. Morcos MM, Gabr AA, Samuel S, Kamel M, el Baz M, et al. (1998) Vitamin D administration to tuberculous children and its value. Boll Chim Farm 137: 157-64.
6. Nursyam EW, Amin Z, Rumende CM, (2006) The effect of vitamin D as supplementary treatment in patients with moderately advanced pulmonary tuberculous lesion. Acta Med Indones. Jan-Mar 38(1): 3-5.
7. Martineau AR, Timms PM, Bothamley GH, Hanifa Y, Islam K, et al. (2011) High-dose vitamin D(3) during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial. Lancet 377(9761): 242-50.
8. Wejse C, Gomes VF, Rabna P, Gustafson P, Aaby P, et al. (2009) Vitamin D as supplementary treatment for tuberculosis: a double-blind, randomized, placebo-controlled trial. Am J Respir Crit Care Med. May 1 179(9): 843-50.
9. Sato S, Tanino Y, Saito J, Nikaido T, Inokoshi Y, et al. (2012) The relationship between 25-hydroxyvitamin D levels and treatment course of pulmonary tuberculosis. Respir Investig. Jun 50(2): 40-5.
10. Koo HK, Lee JS, Jeong YJ, Choi SM, Kang HJ, et al. (2012) Vitamin D deficiency and changes in serum vitamin D levels with treatment among tuberculosis patients in South Korea. Respirology. Jul 17(5): 808-13.
11. Bikle DD, (2008) Vitamin D and the immune system: role in protection against bacterial infection. Current Opinion in Nephrology and Hypertension 179: 348-352.
12. Selvaraj P, (2011) Vitamin D, vitamin D receptor, and cathelicidin in the treatment of tuberculosis. Vitam Horm 86: 307-25.
13. Chang JM, Kuo MC, Kuo HT, Hwang SJ, Tsai JC, et al. (2004) 1-alpha, 25-Dihydroxy vitamin D3 regulates inducible nitric oxide synthase messenger RNA expression and nitric oxide release in macrophage-like RAW 264.7 cells. J Lab Clin Med. Jan 143(1): 14-22.
14. Sly LM, Lopez M, Nauseef WM, Reiner NE, (2001) 1alpha, 25-Dihydroxyvitamin D3-induced monocyte antimycobacterial activity is regulated by phosphatidylinositol 3-kinase and mediated by the NADPH-dependent phagocyte oxidase. Biol Chem. 21 276(38): 35482-93.
15. Marino S, Pawar S, Fuller CL, Reinhart TA, Flynn JL, et al. (2004) Dendritic Cell Trafficking and Antigen Presentation in the Human Immune Response to Mycobacterium tuberculosis.The Journal of Immunology. 173: 494-506.
16. Lichtner M, Rossi R, Mengoni F, Vignoli S, Colacchia B, et al. (2005) Circulating dendritic cells and interferona production in patients with tuberculosis: correlation with clinical outcome and treatment response. Clinical and Experimental Immunology143: 329-337.
17. Rajashree P, Krishnan G, Das SD, (2009) Impaired phenotype and function of monocyte derived dendritic cells in pulmonary tuberculosis. Tuberculosis 89: 77-83.
18. Penna G, Adorini L, (2000) 1{alpha},25-Dihydroxyvitamin D3 Inhibits Differentiation, Maturation, Activation, and Survival of Dendritic cells Leading to Impaired Alloreactive T Cell Activation. J. Immunol 164: 2405-2411.
19. Piemonti L, Monti P, Sironi M, Fraticelli P, Leone BE, et al. (2000) Vitamin D3 affects differentiation, maturation, and function of human monocyte-derived dendritic cells. J Immunol. May 1 164(9): 4443-51.
20. Hewison M, Freeman L, Hughes SV, Evans KN, Bland R, et al. (2003) Differential regulation of vitamin D receptor and its ligand in human monocyte-derived dendritic cells. J Immunol. Jun 1 170(11): 5382-90.
21. Inaba K, Inaba M, Romani N, Aya H, Deguchi M, et al. (1992) Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocytermacrophage colonystimulating factor J. Exp. Med 176: 1693-1702.
22. Aranow C, (2011) Deficiency in vitamin D is associated with increased autoimmunity and an increased susceptibility to infection. Vitamin D and the Immune System. J Investig Med. Aug 59(6): 881-6.
23. Liu PT, Stenger S, Li H, Wenzel L, Tan BH, et al. (2006) Toll-Like Receptor Triggering of a Vitamin D-Mediated Human Antimicrobial Response. SCIENCE 311: 1770-1773.
24. Chocano-Bedoya P, Ronnenberg AG, (2009) Vitamin D and tuberculosis. Nutr Rev 67(5): 289-93.
25. Holick MF, (2007) Vitamin D deficiency. N Engl J Med 19 357(3): 266-81.
26. Malabanan A, Veronikis IE, Holick MF, (1998) Redefining vitamin D insufficiency. Lancet 351: 805-6.
27. Gorman S, Judge MA, Hart PH, (2010) Immune-modifying properties of topical vitamin D: Focus on dendritic cells and T cells. J Steroid Biochem Mol Biol Jul 121(1-2): 247-9.
28. He XY, Xiao L, Chen HB, Hao J, Li J, et al. (2010) T regulatory cells and Th1/Th2 cytokines in peripheral blood from tuberculosis patients. Eur J Clin Microbiol Infect Dis. 29(6): 643-50.
29. Dlugovitzky D, Torres-Morales A, Rateni L, Farroni MA, Largacha C, et al. (1997) Circulating profile of Th1 and Th2 cytokines in tuberculosis patients with different degrees of pulmonary involvement. FEMS Immunol Med Microbiol. Jul 18(3): 203-7.
30. Flynn JL, (2004) Immunology of tuberculosis and implications in vaccine development. Tuberculosis (Edinb) 84: 93-101.
31. Nemeth J, Winkler HM, Boeck L, Adegnika AA, Clement E, et al. (2010) Specific cytokine patterns of pulmonary tuberculosis in Central Africa. Clin Immunol 138: 50-59.
32. Marino S, Myers A, Flynn JL, Kirschner DE, (2010) TNF and IL-10 are major factors in modulation of the phagocytic cell environment in lung and lymph node in tuberculosis: a next-generation two-compartmental model. J Theor Biol 265: 586-598.
33. Handzel ZT, Barak V, Altman Y, Bibi H, Lidgi M, et al. (2007) Increased Th1 and Th2 type cytokine production in patients with active tuberculosis. Isr Med Assoc J 9: 479-483.
34. Toossi Z, Gogate P, Shiratsuchi H, Young T, Ellner JJ, (1996) Enhanced production of TGF-βby blood monocytes from patients with active tuberculosis and presence of TGF-βin tuberculous granulomatous lung lesions. J Immunol 154: 465.
35. Infante-Duarte C, Kamradt T, (1999) Th1/Th2 balance in infection. Springer Semin Immunopathol. 21(3): 317-38.
36. Tan Q, Xie WP, Min R, Dai GQ, Xu CC, et al. (2011) Characterization of Th1- and Th2-type immune response in human multidrug-resistant tuberculosis. Eur J Clin Microbiol Infect Dis. Oct 25.
37. Sano K, Handea K, Tamura G, Shirato K, (1999) Ovalbumin (OVA) and Myocbacterium tuberculosis bacilli cooperatively polarize anti-OVA T-helper cells foward a Th1-dominant phenotype and ameliorate murine tracheal eosinophilia. Am J Resp Cell Mol Biol. 20: 1260-7.
38. Flynn JL, Goldstein MM, Triebold KJ, Sypek J, Wolf S, et al. (1995) IL-12 increases resistance of BALB/c mice to Mycobacterium tuberculosis infection. J Immunol (155) (): 2515-24.
39. Cooper AM, Magram J, Ferrante J, Orme IM, (1997) Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with Mycobacterium tuberculosis. J Exp Med 186: 39-45.
40. Bai X, Wilson SE, Chmura K, Feldman NE, Chan ED, (2004) Morphometric analysis of Th(1) and Th(2) cytokine expression in human pulmonary tuberculosis. Tuberculosis (Edinb) 84(6): 375-85.
41. Domínguez J, De Souza-Galvão M, Ruiz-Manzano J, Latorre I, Prat C, et al. (2009) T-cell responses to the Mycobacterium tuberculosis-specific antigens in active tuberculosis patients at the beginning, during, and after antituberculosis treatment. Diagn Microbiol Infect Dis 63: 43-51.